Get early access! Join the Twelve Data AI Assistant waitlist now.
12.55000 CAD
0.2
1.57%
Last update Sep 9, 3:01 PM EDT
Market closed
Day range
12.53000
12.75
Previous close
12.75
Open
12.75
Access this stock data via API
Subscribe
Innocan Pharma Corporation
12.55
0.20
1.57%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 40.8M 2.6M 196K
Cost of revenue 4.5M 452K 75K
Gross profit 36.3M 2.1M 121K
Operating expense
Research & development 2.1M 1.5M 1.4M
Selling general and admin 35.8M 6.8M 6.2M
Other operating expenses
Operating income -1.7M -6.3M -7.5M
Non operating interest income
Income 0 21K
Expense 9.7K 2K 13K
Other income expense 3.0M 2.4M -2.6M
Pretax income 1.3M -3.9M -10.1M
Tax provision 1.6M 1K 0
Net income -362.8K -3.9M -10.1M
Basic EPS 0.0 0.0 0.0 -0.1
Diluted EPS 0.0 0.0 0.0 -0.1
Basic average shares 387.7M 180.4M 171.3M 154.5M
Diluted average shares 387.7M 180.4M 171.3M 154.5M
EBITDA -1.7M -6.2M -7.4M
Net income from continuing op. -362.8K -3.9M -10.1M
Minority interests -1.6M 125K 44K
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 9 hours 33 minutes

22:26
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EDT, UTC-04:00).